Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novartis Ag ADR
(NY:
NVS
)
104.30
-1.11 (-1.05%)
Streaming Delayed Price
Updated: 12:06 PM EDT, Jun 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
27
28
Next >
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.
Via
InvestorPlace
Novartis' Malaria Treatment Candidate To Move Forward With Phase 3 Development Next Year
November 23, 2022
Via
Benzinga
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
November 23, 2022
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
November 19, 2022
These two rank among the 10 largest pharmaceutical companies on the planet.
Via
The Motley Fool
Novartis (NVS) Q3 2022 Earnings Call Transcript
October 25, 2022
NVS earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Novartis Offers Mixed Earnings Report As It Approaches A Key Spinoff
October 25, 2022
The spinoff will help Novartis become a "pure-play" innovative medicines giant, the company says.
Via
Investor's Business Daily
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
November 22, 2022
On November 13, Enlivex (NASDAQ: ENLV) announced that the first patient has been dose
Via
Benzinga
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
November 21, 2022
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Thoughts For Thursday: Correction Day!
November 17, 2022
The market remains agitated and it looks like it may be a long week from here to Thanksgiving. Yesterday the market remained chiefly in corrective mode, as it was down from the outset.
Via
Talk Markets
Novartis Clocks 4% Drop In Quarterly Sales, Once Again Perks Up Sandoz Earnings Outlook
October 25, 2022
Via
Benzinga
Earnings Scheduled For October 25, 2022
October 25, 2022
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter.
Via
Benzinga
Novartis Mulls Disposing Its Non-Core Ophthalmology and Respiratory Units
November 16, 2022
Novartis AG (NYSE: NVS) is reportedly weighing divesting non-core assets as it seeks to raise money to invest in cutting-edge medicines, people familiar with the matter said.
Via
Benzinga
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023
November 14, 2022
Via
Benzinga
Should Income Investors Buy This High-Yielding Dividend Stock?
November 13, 2022
Novartis' product portfolio and pipeline bode well for its future.
Via
The Motley Fool
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
2 Biotech Stocks That Could Make You Richer
November 04, 2022
Both drugmakers are pretty close to their 52-week highs, but that shouldn't stop investors.
Via
The Motley Fool
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
Via
Benzinga
3 High-Yielding Dividend Stocks That You Can Buy and Hold Forever
October 27, 2022
These stocks are all trading close to their 52-week lows.
Via
The Motley Fool
Cytokinetics CEO: Why It's OK Not Being An Overnight Success
October 25, 2022
The company hopes to come out next year with at least one heart-failure drug.
Via
Investor's Business Daily
Twitter Considers Crypto Wallet, Geopolitical Woes To Keep Tesla Shares Volatile, Juul Explores Possible Bailout: Top Stories Tuesday, Oct. 25
October 25, 2022
Benzinga
Via
Benzinga
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
October 25, 2022
Biosimilars are bringing down prescription drug costs without sacrificing quality.
Via
The Motley Fool
US Stock Futures Down; Big Tech Earnings In Focus
October 25, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Tuesday after recording gains in the previous session. The Dow Jones jumped by more than 400 points on Monday after all the...
Via
Benzinga
Recap: Novartis Q3 Earnings
October 25, 2022
Novartis (NYSE:NVS) reported its Q3 earnings results on Tuesday, October 25, 2022 at 01:00 AM. Here's what investors need to know about the announcement. Earnings Novartis beat estimated earnings by...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
October 24, 2022
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
Novartis Experimental Drug Shows Meaningful Superiority Over Previous Treatment In Rare Blood Disorder
October 24, 2022
Novartis AG's (NYSE: NVS) investigational oral monotherapy iptacopan was superior to anti-C5 therapies (eculizumab or ravulizumab) in adults with paroxysmal nocturnal hemoglobinuria (PNH).
Via
Benzinga
Alcon: Take A Look At Vision Care
October 23, 2022
Alcon AG is a global provider of ophthalmic surgery and vision care products. We have a favorable view of the company’s market position and product pipeline, and note that sales growth has outpaced...
Via
Talk Markets
Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform
October 17, 2022
Allarity Therapeutics Inc. (NASDAQ: ALLR) is a clinical-stage pharmaceutical company focused on oncology treatments.
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.